skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Table of Contents

Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States

Special Considerations Regarding the Use of Antiretroviral Drugs by HIV-Infected Pregnant Women and Their Infants

Pharmacokinetic Changes
Combination Antiretroviral Drug Regimens and Pregnancy Outcome
Nevirapine and Hepatic/Rash Toxicity
Nucleoside Reverse Transcriptase Inhibitor Drugs and Mitochondrial Toxicity
Protease Inhibitor Therapy and Hyperglycemia

Back to Top